Epression of the Apoptosis-Inducing FAS Ligand (FASL) in Human First and Third Trimester Placenta and Choriocarcinoma Cells
Open accessThe DOI matches its OpenAlex record.
Abstract
The Fas (Apo-1/CD95) ligand (FasL) belongs to the tumor necrosis factor family and acts through its receptor (FasR/ Apo-1/CD95) to induce apoptosis in target cells. FasL is expressed in several immunologically privileged sites. Induction of apoptosis by FasL in invading lymphocytes acts as a mechanism of immune privilege and is important in preventing graft rejection. Furthermore, FasL is expressed in certain malignancies and it has been implicated as a possible key mechanism in immune privilege of these tumors. Since the invading placental trophoblast is another very important site with a privileged immune status, we investigated whether FasL is expressed in the normal and tumoral human placenta. For this purpose, mRNA was extracted from first and third trimester human placental samples as well as from JEG3 choriocarcinoma cells and reverse transcribed to obtain cDNAs. These were used as templates for PCR analysis of FasL expression, in which specific primers were employed to amplify an 853 bp fragment spanning the whole FasL coding region. A product of the appropriate length was amplified from normal placenta as well as from the choriocarcinoma cells. Expression of FasL protein was confirmed by Western Blot and was localized to trophoblast by immunohistochemistry using a FasL-specific antibody. Expression of FasL in the human placenta indicates that induction of apoptosis in lymphocytes by the invading trophoblast could be an important mechanism implicated in the immune tolerance of the fetal semi-allograft.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Ishihara, N., Matsuo, H., Murakoshi, H., Laoag-Fernandez, J. B., Samoto, T., & Maruo, T. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.119176 · Cited by 513
Santner-Nanan, B., Peek, M. J., Khanam, R., Richarts, L., Zhu, E., Fazekas de St Groth, B., & Nanan, R. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901154 · Cited by 469
Placental apoptosis in preeclampsia
Allaire, A. (2000) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(00)00895-4 · Cited by 434
Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta
Huppertz, B., Frank, H.-G., Kingdom, J. C. P., Reister, F., & Kaufmann, P. (1998) · Histochemistry and Cell Biology · doi:10.1007/s004180050311 · Cited by 402
Direct and Indirect Inhibition of Th1 Development by Progesterone and Glucocorticoids
Miyaura, H., & Iwata, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1087 · Cited by 361
Metadata
- Authors
- Bamberger, A., Schulte, H. M., Thuneke, I., Erdmann, I., Bamberger, C. M., & Asa, S. L.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- Oxford University Press
- Published
- 1997-09-01
- Volume
- 82
- Issue
- 9
- Pages
- 3173-3175
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2038508002
- Cited by
- 109
- References
- 0
- FWCI
- 4.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epression of the Apoptosis-Inducing FAS Ligand (FASL) in Human First and Third Trimester Placenta and Choriocarcinoma Cells. https://app.cochat.ai/papers/10.1210/jc.82.9.3173
- The paper
- Bamberger, A., Schulte, H. M., Thuneke, I., Erdmann, I., Bamberger, C. M., & Asa, S. L. (1997). Epression of the Apoptosis-Inducing FAS Ligand (FASL) in Human First and Third Trimester Placenta and Choriocarcinoma Cells. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.82.9.3173
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.